|
AU2018201997B2
(en)
|
|
Peptides which inhibit activated receptors and their use in cosmetic or pharmaceutical compositions
|
|
WO2015183963A3
(en)
|
|
Therapeutic compositions including redox-active parabenzoquinones and uses thereof
|
|
BR112014008789A2
(pt)
|
|
prevenção e tratamento de condições oculares
|
|
MX378707B
(es)
|
|
Compuestos para el tratamiento de enfermedades y trastornos oftalmicos.
|
|
BR112015007814A2
(pt)
|
|
diagnóstico, prevenção e tratamento de doenças da articulação
|
|
EA201101518A1
(ru)
|
|
Фармацевтическая композиция для применения в медицинской и ветеринарной офтальмологии
|
|
HK1204988A1
(en)
|
|
Methods and compositions for preventing or treating ophthalmic conditions
|
|
MX2011008616A
(es)
|
|
Peptidos utiles en el tratamiento y/o cuidado de la piel , mucosas y/o cuero cabelludo y su uso en composiciones cosmeticas o farmaceuticas.
|
|
TW201129368A
(en)
|
|
Peptides used in the treatment and/or care of the skin, mucous membranes and/or hair and its use in cosmetic or pharmaceutical compositions
|
|
WO2012080729A3
(en)
|
|
Casein kinase 1delta (ck1delta) inhibitors and their use in the treatment of neurodegenerative diseases such as tauopathies
|
|
WO2013186777A3
(en)
|
|
Use of blocking agents of bone morphogenie protein (bmp) signaling for the treatment of neuroinflammatory and neurodegenerative diseases
|
|
EP3606570B8
(en)
|
|
Collagen peptide-based medicament compositions for use in the treatment of ocular diseases, disorders or wounds
|
|
CY1117854T1
(el)
|
|
Πεπτιδικη φαρμακοτεχνικη μορφη για τοπικη οφθαλμικη χρηση
|
|
EP3653205A3
(en)
|
|
Oxymethazoline for topical ophthalmic administration and uses thereof
|
|
EP3501532A3
(en)
|
|
Therapeutic compositions including frataxin, lactoferrin, and mitochondrial energy generating enzymes, and uses thereof
|
|
MY190257A
(en)
|
|
Optimised subcutaneous therapeutic agents
|
|
WO2014161004A3
(en)
|
|
Compositions and methods for the delivery of drugs to the ocular surface by contact lenses
|
|
BRPI1008815A2
(pt)
|
|
composições farmacêuticas compreendendo peptídeos inibidores de tgf-beta1
|
|
WO2015048188A8
(en)
|
|
Modified fibroblast growth factors for the treatment of ocular disorders
|
|
NZ719321A
(en)
|
|
Storage stable lyophilized tripeptide formulations
|
|
CL2020001426A1
(es)
|
|
Composición tópica oftálmica que comprende ácido dobesilico para tratar enfermedades del segmento posterior del ojo.
|
|
WO2015183984A3
(en)
|
|
Therapeutic compositions including tocopherol and uses thereof
|
|
WO2012138911A3
(en)
|
|
Conjugates of anti-hiv drugs and somatostatin analogs
|
|
EP4364810A3
(en)
|
|
Topical formulations and uses thereof
|
|
IN2014DN09240A
(th)
|
|
|